Kristine Ball
Chief Executive Officer at Antiva Biosciences, Inc.- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Antiva Biosciences, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
Apr 2023 - Present
San Francisco Bay Area
-
-
-
Atreca, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Board Member
-
2020 - Present
-
-
-
Soteria Biotherapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
2020 - 2022
-
-
-
Forty Seven Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Board Member
-
2018 - 2020
Forty Seven was acquired by Gilead in 2020
-
-
-
Menlo Therapeutics, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
SVP, Corporate Strategy and Chief Financial Officer
-
2017 - 2020
Menlo merged with Vyne in 2020.
-
-
-
Relypsa
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
SVP, Chief Financial Officer
-
2012 - 2016
Redwood City, CA Relypsa was acquired by Vifor in 2016.
-
-
-
KAI Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
SVP, Chief Financial Officer
-
2005 - 2012
South San Francisco, CA KAI was acquired by Amgen in 2012.
-
-
-
Exelixis
-
Greece
-
Business Consulting and Services
-
VP Finance
-
2000 - 2005
South San Francisco, CA
-
-
-
EY
-
Entertainment Providers
-
1 - 100 Employee
-
Senior Manager
-
1998 - 2000
Palo Alto, CA
-
-
-
-
Manager
-
1993 - 1997
Boston, MA
-
-
Education
-
Babson College
Community
You need to have a working account to view this content.
Click here to join now
